![Jesse McCool](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Jesse McCool
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Wheeler Bio, Inc.
![]() Wheeler Bio, Inc. BiotechnologyHealth Technology Wheeler Bio, Inc. is a biomanufacturing company based in the biomanufacturing metro of Oklahoma City, OK. Wheeler Bio's technology platform, Portable CMC™, simplifies the path between drug discovery and clinical manufacturing, providing a new bridge for translating discoveries to first-in-human trials. The company's hub-and-spoke operational model, integrated with biotechs and discovery CROs, revolutionizes the speed of drug development. Wheeler Bio offers a different CDMO model to help innovators go faster with candidates, accelerating processes for plasmids, cell lines, characterization, and more. The company's biologics CDMO facility offers protein expression, cell line development, process development, analytical development, and material supply and testing capabilities. The company was founded by a team of industry experts and strategic investors, led by Jesse McCool who has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Vorstandsvorsitzender | - | - | |
Gründer | - | - |
Karriereverlauf von Jesse McCool
Ehemalige bekannte Positionen von Jesse McCool
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Direktor/Vorstandsmitglied | 01.01.2014 | - |
Vorstandsvorsitzender | 30.03.2020 | - | |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2014 | 30.03.2020 | |
Corporate Officer/Principal | 01.10.2013 | 01.01.2014 |
Ausbildung von Jesse McCool
University of Massachusetts | Doctorate Degree |
Dartmouth College | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 5 |
Operativ
Director/Board Member | 2 |
Chief Executive Officer | 2 |
Doctorate Degree | 2 |
Sektoral
Health Technology | 3 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Cytovance Biologics, Inc.
![]() Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
Wheeler Bio, Inc.
![]() Wheeler Bio, Inc. BiotechnologyHealth Technology Wheeler Bio, Inc. is a biomanufacturing company based in the biomanufacturing metro of Oklahoma City, OK. Wheeler Bio's technology platform, Portable CMC™, simplifies the path between drug discovery and clinical manufacturing, providing a new bridge for translating discoveries to first-in-human trials. The company's hub-and-spoke operational model, integrated with biotechs and discovery CROs, revolutionizes the speed of drug development. Wheeler Bio offers a different CDMO model to help innovators go faster with candidates, accelerating processes for plasmids, cell lines, characterization, and more. The company's biologics CDMO facility offers protein expression, cell line development, process development, analytical development, and material supply and testing capabilities. The company was founded by a team of industry experts and strategic investors, led by Jesse McCool who has been the CEO since incorporation. | Health Technology |
- Börse
- Insiders
- Jesse McCool
- Erfahrung